Urinary tract infections are among the most common types of illnesses among all ages.
However, in some instances, a lack of accurate and efficient diagnostics has led to UTIs being misdiagnosed or inappropriately treated.
Conventional laboratory culture techniques can take 3-7 days to return. These techniques may be limited in that they only detect the most common pathogens like E coli; yet, there are numerous other pathogens that cause UTIs. These are usually missed because they don’t easily grow in a culture medium.
Clinicians have often been left with no choice but to prescribe broad-spectrum antibiotics while awaiting test results. Unfortunately, this has contributed to the growing epidemic of antibiotic resistance.
Clinical Solution
Vikor Scientific™ offers the clinician access to one of the most advanced molecular methodologies for pathogen detection, quantification, and resistance gene identification. Vikor delivers rapid and precise results simultaneously with actionable guidance, which incorporates regional sensitivity and susceptibility patterns, medication costs, antibiotic spectrum of activity, and treatment guidance for providers to consider when determining what’s best for their patients.
The end product is a patient-centered, value-based care solution that enables providers to make informed treatment decisions that could avoid inappropriate therapy, excess costs, adverse drug events and the progression of disease.
Clinical Advantages
- Prevents delays in diagnosis and treatment (*results within 24 to 48 hours post specimen arrival to lab)
- Detects polymicrobial infections simultaneously
- Identifies up to 49 antibiotic resistance genes in 13 antibiotic classes including Methicillin, Carbapenem and Vancomycin resistance
- Reduced susceptibility to being affected by concurrent antibiotic therapy
- Can help reduce risks of drug exposure and adverse events
- Can help decrease the progression and spread of infection
- Provides up-to-date regional sensitivity and susceptibility patterns
- Improves selection of narrow-spectrum antibiotics
- Prepares clinicians to make cost-effective treatment decisions
- Easily accessible results (mobile, web-portal or EMR integration)
* Test results could be delayed in some circumstances when there is error in clerical documentation, collections, lab handling, or a delay in shipping.
